Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease
- Authors: Danilova NA1, Abdulkhakov SR1,2, Grigoryeva TV1, Markelova MI1, Vasilyev IY.1, Boulygina EA1, Ardatskaya MD3, Pavlenko AV4, Tyakht AV5, Odintsova AK.6, Abdulkhakov RA2
-
Affiliations:
- Kazan Federal University
- Kazan State Medical University of the Ministry of Health of the Russian Federation
- Central State Medical Academy of Administrative Department of the President of the Russian Federation
- Federal Research and Clinical Centre of Physical-Chemical Medicine of the Federal Medical and Biological Agency
- Institute of Gene Biology of RAS
- Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
- Issue: Vol 91, No 4 (2019)
- Pages: 13-20
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33561
- DOI: https://doi.org/10.26442/00403660.2019.04.000211
- ID: 33561
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
N A Danilova
Kazan Federal University
Email: danilova.natalya.87@mail.ru
м.н.с. OpenLab «Генные и клеточные технологии» Института фундаментальной медицины и биологии ФГАОУ ВО «КФУ»; тел.: +7(962)568-54-00; ORCID: 0000-0002-7137-5032 Kazan, Russia
S R Abdulkhakov
Kazan Federal University; Kazan State Medical University of the Ministry of Health of the Russian Federationк.м.н., с.н.с. OpenLab «Генные и клеточные технологии» Института фундаментальной медицины и биологии ФГАОУ ВО «КФУ»; ассистент каф. общей врачебной практики ФГБОУ ВО «КГМУ»; ORCID: 0000-0001-9542-3580 Kazan, Russia
T V Grigoryeva
Kazan Federal Universityк.б.н., с.н.с. OpenLab «Омиксные технологии» Института фундаментальной медицины и биологии ФГАОУ ВО «КФУ»; ORCID: 0000-0001-5314-7012 Kazan, Russia
M I Markelova
Kazan Federal Universityм.н.с. OpenLab «Омиксные технологии» Института фундаментальной медицины и биологии ФГАОУ ВО «КФУ»; ORCID: 0000-0001-7445-2091 Kazan, Russia
I Yu Vasilyev
Kazan Federal Universityм.н.с. OpenLab «Омиксные технологии» Института фундаментальной медицины и биологии ФГАОУ ВО «КФУ»; ORCID: 0000-0001-7799-1728 Kazan, Russia
E A Boulygina
Kazan Federal Universityн.с. OpenLab «Омиксные технологии» Института фундаментальной медицины и биологии ФГАОУ ВО «КФУ»; ORCID: 0000-0003-3458-1176 Kazan, Russia
M D Ardatskaya
Central State Medical Academy of Administrative Department of the President of the Russian Federationд.м.н., проф. каф. гастроэнтерологии ФГБУ ДПО «ЦГМА» Управления делами Президента РФ Павленко Александр Владимирович - н.с. ФГБУ «ФНКЦ ФХМ» ФМБА России Moscow, Russia
A V Pavlenko
Federal Research and Clinical Centre of Physical-Chemical Medicine of the Federal Medical and Biological Agencyн.с. ФГБУ «ФНКЦ ФХМ» ФМБА России Moscow, Russia
A V Tyakht
Institute of Gene Biology of RASк.б.н., н.с. лаб. моделирования и терапии наследственных заболеваний Института биологии гена РАН; ORCID: 0000-0002-7358-2537 Moscow, Russia
A Kh Odintsova
Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstanк.м.н., зав. гастроэнтерологическим отд-нием Республиканской клинической больницы Kazan, Russia
R A Abdulkhakov
Kazan State Medical University of the Ministry of Health of the Russian Federationд.м.н., проф. каф. госпитальной терапии ФГБОУ ВО «КГМУ»; ORCID: 0000-0002-1509-6776 Kazan, Russia
References
- Лазебник Л.Б., Конев Ю.В. Новое понимание роли микробиоты в патогенезе метаболического синдрома. Consilium Medicum (Прил.). 2014;(8):77-82.
- Ситкин С.И., Вахитов Т.Я., Ткаченко Е.И. Орешко Л.С., Жигалова Т.Н., Радченко В.Г., Селиверстов П.В., Авалуева Е.Б., Суворова М.А., Комличенко Э.В. Микробиота кишечника при язвенном колите и целиакии. Экспериментальная и клиническая гастроэнтерология. 2017;1(137):8-30.
- Li K.Y, Wei J.P, Gao S.Y, Zhang Y.Y, Wang L.T, Liu G. Fecal microbiota in pouchitis and ulcerative colitis. World J Gastroenterol. 2016;22(40):8929-39. doi: 10.3748/wjg.v22.i40.8929
- Presley L.L, Ye J, Li X, Le Blanc J, Zhang Z, Ruegger P.M, Allard J, Mc Govern D, Ippoliti A, Roth B, Cui X, Jeske D.R, Elashoff D, Goodglick L, Braun J, Borneman J. Host - microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal - luminal interface. Inflamm Bowel Dis. 2012 Mar;18(3):409-17. doi: 10.1002/ibd.21793
- Ganji L, Alebouyeh M, Shirazi M.H, Eshraghi S.S, Mirshafiey A, Daryani N.E, Zali M.R. Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis. Gastroenterol Hepatol Bed Bench. 2016;9(4):325-30.
- Vrakas S, Mountzouris K.C, Michalopoulos G, Karamanolis G, Papatheodoridis G, Tzathas C, Gazouli M. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease. PLoS One. 2017;12(1):e0170034. doi: 10.1371/journal.pone.0170034
- Ситкин С.И., Вахитов Т.Я., Демьянова Е.В. Микробиом, дисбиоз толстой кишки и воспалительные заболевания кишечника: когда функция важнее таксономии. Альманах клинической медицины. 2018;46(5):396-425. doi: 10.18786/2072-0505-2018-46-5-396-425
- Mondot S, de Wouters T, Doré J, Lepage P. The human gut microbiome and its dysfunctions. Dig Dis. 2013;31:278-85. doi: 10.1111/nyas.13033
- Qin J, Li R, Raes J, Arumugam M, Burgdorf K.S, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende D.R, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto J.M, Hansen T, Le Paslier D, Linneberg A, Nielsen H.B, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich S.D, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65. doi: 10.1038/nature08821
- Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol. 2015;37:47-55. doi: 10.1007/s00281-014-0454-4
- Gill S.R, Pop M, Deboy R.T, Eckburg P.B, Turnbaugh P.J, Samuel B.S, Gordon J.I, Relman D.A, Fraser-Liggett C.M, Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science. 2006;5778:1355-9. doi: 10.1126/science.1124234
- Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet J.P, Ugarte E, Muñoz-Tamayo R, Paslier D.L, Nalin R, Dore J, Leclerc M. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol. 2009;11(10):2574-84. doi: 10.1111/j.1462-2920.2009.01982.x
- Eckburg P.B, Bik E.M, Bernstein C.N, Purdom E, Dethlefsen L, Sargent M, Gill S.R, Nelson K.E, Relman D.A. Diversity of the Human Intestinal Microbial Flora. Science. 2005;308(5728):1635-8. doi: 10.1126/science.1110591
- Tyakht A.V, Kostryukova E.S, Popenko A.S, Belenikin M.S, Pavlenko A.V, Larin A.K, Karpova I.Y, Selezneva O.V, Semashko T.A, Ospanova E.A, Babenko V.V, Maev I.V, Cheremushkin S.V, Kucheryavyy Y.A, Shcherbakov P.L, Grinevich V.B, Efimov O.I, Sas E.I, Abdulkhakov R.A, Abdulkhakov S.R, Lyalyukova E.A, Livzan M.A, Vlassov V.V, Sagdeev R.Z, Tsukanov V.V, Osipenko M.F, Kozlova I.V, Tkachev A.V, Sergienko V.I, Alexeev D.G, Govorun V.M. Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun. 2013;4:2469. doi: 10.1038/ncomms3469
- Langmead B, Salzberg S.L. Fast gapped - read alignment with Bowtie 2. Nat Methods. 2012;9(4):357-9. doi: 10.1038/nmeth.1923
- Truong D.T, Franzosa E.A, Tickle T.L, Scholz M, Weingart G, Pasolli E, Tett A, Huttenhower C, Segata N. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12:902-3. doi: 10.1038/nmeth.3589
- Abubucker S, Segata N, Goll J, Schubert A.M, Izard J, Cantarel B.L, Rodriguez-Mueller B, Zucker J, Thiagarajan M, Henrissat B, White O, Kelley S.T, Methé B, Schloss P.D, Gevers D, Mitreva M, Huttenhower C. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol. 2012:8:e1002358. doi: 10.1371/journal.pcbi.1002358
- Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, Matsui T, Fujiyama Y, Matsumoto T. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J Gastroenterol. 2012;47:1298-307. doi: 10.1007/s00535-012-0605-0
- Ohkusa T, Sato N, Ogihara T, Morita K, Ogawa M, Okayasu I. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species - specific antibody. J Gastroenterol Hepatol. 2002;17(8):849-53.
- Ott S.J, Musfeldt M, Wenderoth D.F, Hampe J, Brant O, Fölsch U.R, Timmis K.N, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685-93. doi: 10.1136/gut.2003.025403
- Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, Yantiss R, Orsi R.H, Wiedmann M, Mc Donough P, Kim S.G, Berg D, Schukken Y, Scherl E, Simpson K.W. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISMEJ. 2007;1:403-18. doi: 10.1038/ismej.2007.52
- Frank D.N, St Amand A.L, Feldman R.A, Boedeker E.C, Harpaz N, Pace N.R. Molecular - phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780-5. doi: 10.1073/pnas.0706625104
- Gophna U, Sommerfeld K, Gophna S, Doolittle W.F, Veldhuyzen van Zanten S.J. Differences between tissue - associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2006 Nov; 44(11):4136-41. doi: 10.1128/JCM.01004-06
- Bernstein C.N, Forbes J.D. Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases. Inflamm Intest Dis. 2017;2(2):116-23. doi: 10.1159/000481401
- Matsuoka K, Mizuno S, Hayashi A, Hisamatsu T, Naganuma M, Kanai T. Fecal microbiota transplantation for gastrointestinal diseases. Keio J Med. 2014;63(4):69-74. doi: 10.2302/kjm.2014-0006-RE
- Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán L.G, Gratadoux J.J, Blugeon S, Bridonneau C, Furet J.P, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière H.M, Doré J, Marteau P, Seksik P, Langella P. Faecalibacterium prausnitzii is an anti - inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731-6. doi: 10.1073/pnas.0804812105
- Sokol H, Seksik P, Furet J.P, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183-9. doi: 10.1002/ibd.20903
- Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C. A microbial signature for Crohn’s disease. Gut. 2017;66:813-22. doi: 10.1136/gutjnl-2016-313235
- Tyakht A.V, Manolov A.I, Kanygina A.V, Ischenko D.S, Kovarsky B.A, Popenko A.S, Pavlenko A.V, Elizarova A.V, Rakitina D.V, Baikova J.P, Ladygina V.G, Kostryukova E.S, Karpova I.Y, Semashko T.A, Larin A.K, Grigoryeva T.V, Sinyagina M.N, Malanin S.Y, Shcherbakov P.L, Kharitonova A.Y, Khalif I.L, Shapina M.V, Maev I.V, Andreev D.N, Belousova E.A, Buzunova Y.M, Alexeev D.G, Govorun V.M. Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn’s disease discovered using metagenomic and genomic analyses. BMC Genomics. 2018;19:968. doi: 10.1186/s12864-018-5306-5
- Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J. Reduced diversity of faecalmicrobiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-11. doi: 10.1136/gut.2005.073817
- Mirsepasi-Lauridsen H.C, Vrankx K, Engberg J, Friis-Møller A, Brynskov J, Nordgaard-Lassen I, Petersen A.M, Krogfelt K.A. Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease. Front Med. 2018. doi: 10.3389/fmed.2018.00304
- Ghavami S.B, Rostami E, Sephay A.A, Shahrokh S, Balaii H, Aghdaei H.A, Zali M.R. Alterations of the human gut Methanobrevibacter smithii as a biomarker for inflammatory bowel diseases. Microb Pathog. 2018;117:285-9. doi: 10.1016/j.micpath.2018.01.029
- Ситкин С.И., Ткаченко Е.И., Вахитов Т.Я. Филометаболическое ядро микробиоты кишечника. Альманах клинической медицины. 2015;(40):12-34. doi: 10.18786/2072-0505-2015-40-12-34
- Fujimoto T, Imaeda H, Takahashi K, Kasumi E, Bamba S, Fujiyama Y, Andoh A. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol. 2013;28:613-9. doi: 10.1111/jgh.12073
- Machiels K, Joossens M, Sabino J, de Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, van Immerseel F, Verbeke K, Ferrante M, Verhaegen J, Rutgeerts P, Vermeire S. A decrease of the butyrate - producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2013;63:1275-83. doi: 10.1136/gutjnl-2013-304833
- Hall A.B, Yassour M, Sauk J, Garner A, Jiang X, Arthur T, Lagoudas G.K, Vatanen T, Fornelos N, Wilson R, Bertha M, Cohen M, Garber J, Khalili H, Gevers D, Ananthakrishnan A.N, Kugathasan S, Lander E.S, Blainey P, Vlamakis H, Xavier R.J, Huttenhower C. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Medicine. 2017;9:103. doi: 10.1186/s13073-017-0490-5
- Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Sugimoto M, Andoh A. Reduced abundance of butyrate - producing bacteria species in the fecal microbial community in Crohn’s disease. Digestion. 2016;93(1):59-65. doi: 10.1159/000441768
- Png C.W, Lindén S.K, Gilshenan K.S, Zoetendal E.G, Mc Sweeney C.S, Sly L.I, Mc Guckin M.A, Florin T.H. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105(11):2420-8. doi: 10.1038/ajg.2010.281
- Pitcher M.C, Beatty E.R, Cummings J.H. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut. 2000;46:64-72. doi: 10.1136/gut.46.1.64
- Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11(1):1-10. doi: 10.1007/s12328-017-0813-5
- Deplancke B, Finster K, Graham W.V, Collier C.T, Thurmond J.E, Gaskins H.R. Gastrointestinal and microbial responses to sulfate - supplemented drinking water in mice. Exp Biol Med (Maywood). 2003;228(4):424-33. doi: 10.1177/153537020322800413
- Sartor R.B, Wu G.D. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology. 2016;152(2):327-39. doi: 10.1053/j.gastro.2016.10.012
- Захарова И.Н., Ардатская М.Д., Свинцицкая В.И., Сугян Н.Г., Елезова Л.И., Гадзова И.С. Метаболическая активность кишечной микрофлоры у детей на фоне применения cинбиотика, содержащего bifidobacterium bb-12, lactobacillus acidophilus la-5 и фруктоолигосахарид. Педиатрия. 2011;(3):118-24.
- Huda-Faujan N, Abdulamir A.S, Fatimah A.B, Muhammad Anas O, Shuhaimi M, Yazid A.M, Loong Y.Y. The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J. 2010;4:53-8. doi: 10.2174/1874091X01004010053
- Hamer H.M, Jonkers D, Venema K, Vanhoutvin S, Troost F.J, Brummer R.J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27(2):104-19. doi: 10.1111/j.1365-2036.2007.03562.x
- Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, Kamada N, Sakuraba A, Yajima T, Higuchi H, Inoue N, Ogata H, Iwao Y, Nomoto K, Tanaka R, Hibi T. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol. 2008;298:463-72. doi: 10.1016/j.ijmm.2007.07.016
![](/img/style/loading.gif)